Excimer Lamp Versus Excimer Laser in Vitiligo Treatment

This study has been completed.
Sponsor:
Information provided by:
Centre Hospitalier Universitaire de Nice
ClinicalTrials.gov Identifier:
NCT00696358
First received: June 10, 2008
Last updated: October 30, 2008
Last verified: October 2008

June 10, 2008
October 30, 2008
Not Provided
Not Provided
Repigmentation rate in the treated areas [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00696358 on ClinicalTrials.gov Archive Site
Tolerance and safety of the treatments [ Time Frame: 12 weeks ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
Excimer Lamp Versus Excimer Laser in Vitiligo Treatment
Comparative Study of 308nm Excimer Lamp and 308nm Excimer Laser in the Treatment of Vitiligo

308 nm excimer lamp and 308 nm excimer laser have both provide interesting results in treating vitiligo. They have the same wavelength but the type of emission of the photons is different. To date there is no direct comparative data concerning these two devices in this indication.

The aim of the study is to make an intra-individual prospective comparison between these two phototherapies.

Not Provided
Interventional
Phase 3
Not Provided
Vitiligo
  • Radiation: 308nm excimer lamp
    50 mJ/cm² below the MED (minimal erythemal dose) and progressive increase Twice a week for 12 weeks
  • Radiation: 308nm excimer laser
    50 mJ/cm² below the MED (minimal erythemal dose) and progressive increase Twice a week for 12 weeks (same doses will be used between the 2 arms)
  • Active Comparator: A
    308 nm excimer lamp
    Intervention: Radiation: 308nm excimer lamp
  • Active Comparator: B
    308 nm excimer laser
    Intervention: Radiation: 308nm excimer laser
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • patient above 18
  • vitiligo for more than 3 months
  • at least 2 vitiligo symmetric patches more than 10cm²
  • to read and understand the inform consent
  • to have a social security number
  • non pregnant for women

Exclusion Criteria:

  • pregnant women
  • keloids
  • history of radiotherapy or skin cancer in the treated areas
  • treatment for vitiligo in the past 4 weeks
  • phototherapy in the past 12 weeks; history of photodermatosis
  • treatment inducing photosensibilization
  • immunosuppression
  • patient who participated in a study in the past 3 months
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
France
 
NCT00696358
NICE-VIT1
Not Provided
Not Provided
Centre Hospitalier Universitaire de Nice
Not Provided
Not Provided
Centre Hospitalier Universitaire de Nice
October 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP